Legend Biotech (LEGN) Invested Capital: 2019-2025
Historic Invested Capital for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to $1.0 billion.
- Legend Biotech's Invested Capital fell 9.39% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 9.39%. This contributed to the annual value of $1.3 billion for FY2024, which is 14.04% down from last year.
- Legend Biotech's Invested Capital amounted to $1.0 billion in Q3 2025, which was down 2.34% from $1.0 billion recorded in Q2 2025.
- Legend Biotech's Invested Capital's 5-year high stood at $1.5 billion during Q4 2023, with a 5-year trough of $206,451 in Q1 2021.
- Its 3-year average for Invested Capital is $1.2 billion, with a median of $1.2 billion in 2024.
- As far as peak fluctuations go, Legend Biotech's Invested Capital soared by 358,900.44% in 2022, and later dropped by 17.70% in 2024.
- Legend Biotech's Invested Capital (Quarterly) stood at $1.0 billion in 2021, then increased by 14.23% to $1.1 billion in 2022, then skyrocketed by 31.32% to $1.5 billion in 2023, then dropped by 14.04% to $1.3 billion in 2024, then fell by 9.39% to $1.0 billion in 2025.
- Its Invested Capital was $1.0 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.0 billion in Q1 2025.